MyFinsight
Home
Blog
About
Contact
Download
Download image
Grant income
$552,576
Interest income
$85,410
Net loss
-$1,999,397
Other income, net
$620,513
Other
-$34
Interest expense
$17,439
Loss from operations
-$2,619,910
Total operating
expenses
$2,619,910
General and
administrative
$1,455,173
Research and development
$1,164,737
Back
Back
Income Statement
source: myfinsight.com
Anebulo Pharmaceuticals, Inc. (ANEB)
Anebulo Pharmaceuticals, Inc. (ANEB)